Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Female libido drug remains in limbo
Yahoo/AP
Wednesday, December 11, 2013 - 8:38am
tags:
female sexual dysfunction, Sprout Pharmaceuticals, flibanserin
Does Pfizer Have a Bright Future?
Wall St Cheat Sheet
Wednesday, December 11, 2013 - 8:37am
tags:
Pfizer
Geron: Is Imetelstat The 'Aspirin' Of Cancer?
Seeking Alpha
Wednesday, December 11, 2013 - 8:36am
tags:
Geron, imetelstat, stem cells, cancer
Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large
Forbes
Wednesday, December 11, 2013 - 8:34am
tags:
hepatitis C, drug pricing, Gilead Sciences, Express Scripts
CVS, Cardinal Health To Start Generic Drug Supplier
Bloomberg
Tuesday, December 10, 2013 - 12:23pm
tags:
Cardinal Health, generics, CVS
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tuesday, December 10, 2013 - 11:36am
tags:
Verastem, Cell Therapeutics, Novartis, Geron, imetelstat, Jakavi, myelofibrosis, tosedostat, AML, VS-5584
Novartis/Penn's customized T cell wows ASH with stellar leukemia data
Fierce Biotech
Tuesday, December 10, 2013 - 10:48am
tags:
Novartis, acute lymphoblastic leukemia, CAR T therapy, CTL019
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tuesday, December 10, 2013 - 10:47am
tags:
hepatitis C, Enanta Pharmaceuticals, ABT-450, AbbVie
Police probe Novo Nordisk for late disclosure of drug setback
Yahoo/Reuters
Tuesday, December 10, 2013 - 10:45am
tags:
Novo Nordisk, Tresiba
Teva to Miss 2014 Estimates If Copaxone Generics Allowed
Bloomberg
Tuesday, December 10, 2013 - 10:44am
tags:
Teva, Copaxone, generics, MS, multiple sclerosis
Pfizer Needs an Aspirin After Supreme Court Rejects Appeal
Wall St Cheat Sheet
Tuesday, December 10, 2013 - 10:43am
tags:
Pfizer, Supreme Court, Neurontin
Bristol drug for fat disorder may work, but risky - FDA staff
Reuters
Tuesday, December 10, 2013 - 9:46am
tags:
Bristol-Myers Squibb, FDA, metreleptin
J&J taps UK research hubs
The Telegraph, UK
Tuesday, December 10, 2013 - 9:44am
tags:
JNJ, R&D, UK
Boehringer to Pay $931,000 Fine Over Lost Pradaxa Files
Bloomberg
Tuesday, December 10, 2013 - 9:41am
tags:
Boehringer Ingelheim, Pradaxa
Novartis Said to Weigh Animal-Health Asset Swap
Bloomberg
Tuesday, December 10, 2013 - 9:38am
tags:
Novartis, animal health, Merck
EU regulators fine J&J, Novartis 16 mln euros for generic drug deal
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:25am
tags:
Europe, Novartis, generics, JNJ, Fentanyl
Merck moves Alzheimer's drug into big trial after safety review
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:22am
tags:
Merck, Alzheimer's disease, MK-8931
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:21am
tags:
FDA, AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
Takeda Drug for Bowel Diseases Wins U.S. Panel's Backing
Bloomberg
Tuesday, December 10, 2013 - 9:18am
tags:
Takeda, FDA, advisory panels, vedolizumab
If Arena Has What It Takes, Why Is It Down?
Seeking Alpha
Tuesday, December 10, 2013 - 9:16am
tags:
Arena Pharmaceuticals, obesity, Belviq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.